Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Nordic Nanovector ASA ( (DE:8NN) ) has shared an announcement.
Thor Medical ASA has announced the appointment of Therese Kvehaugen as Executive Vice President of Human Resources and Mathias Nilsen Reierth as Head of Communications and Corporate Affairs. These strategic additions to the executive management team are aimed at supporting the company’s growth into a global leader in the sustainable supply of alpha isotopes for targeted cancer therapies. The new hires bring extensive experience in HR and strategic communications, which is expected to aid Thor Medical’s transition from a pioneering phase to an industrial-scale supplier in the targeted cancer therapies market.
More about Nordic Nanovector ASA
Thor Medical ASA is an emerging supplier of radionuclides, primarily focusing on alpha particle emitters derived from naturally occurring thorium. The company employs a proprietary production process that avoids irradiation or nuclear reactors, ensuring a reliable, environmentally friendly, and cost-efficient supply of alpha-emitters for the radiopharmaceutical industry. Headquartered in Oslo, Norway, Thor Medical is listed on the Oslo Stock Exchange under the ticker symbol ‘TRMED’.
Average Trading Volume: 3,360,740
Current Market Cap: NOK1.27B
For an in-depth examination of 8NN stock, go to TipRanks’ Overview page.